Lowell Schiller is the Chief Legal and Regulatory Officer of Aetion, a health care technology company that provides decision grade real world evidence analytics to biopharma companies, payers, and regulatory agencies.
Previously, Lowell served in several senior leadership roles at the U.S. Food and Drug Administration, most recently as the Principal Associate Commissioner for Policy. In this role, Lowell led FDA’s Office of Policy, managed agency-wide development of regulations and guidance, and provided policy leadership on cross-cutting and high-profile issues across FDA’s jurisdiction. Earlier in his tenure at FDA, Lowell served as FDA’s Acting Chief Counsel and as the Senior Counselor to the Commissioner.
Prior to joining FDA, Lowell served as Senior Counsel to Chairman Lamar Alexander on the Senate Committee on Health, Education, Labor, and Pensions (HELP). Lowell’s work for the HELP Committee included conducting congressional investigations and other oversight, as well as helping enact legislation including the 21st Century Cures Act. Earlier in his career, Lowell was a litigator in private practice who specialized in appeals, dispositive motions, and disputes involving federal agencies.
Lowell clerked for the Honorable Jane R. Roth of the United States Court of Appeals for the Third Circuit. He earned his law degree from Harvard Law School and his undergraduate degree from Princeton University.